The first Iterum Therapeutics Plc trade was made in Q4 2020.
Since then Jim Simons bought shares eleven more times and sold shares on nine occasions. The investor completely sold their stake between Q3 2025 and Q4 2025.
Avg closing price
Price range
Sold -81.7k shares
Q4 2025
Avg closing price
$0.54
Price range
$0.29
-
$0.81
Sold 82.7% shares (-390k shares)
Q3 2025
Avg closing price
$0.78
Price range
$0.63
-
$1.13
Increased shares by 95.9% (+231k shares)
Q2 2025
Avg closing price
$1.04
Price range
$0.92
-
$1.39
Sold 45.1% shares (-198k shares)
Q1 2025
Avg closing price
$1.49
Price range
$1.23
-
$1.98
New holding (+439k shares)
Q4 2024
Avg closing price
$1.58
Price range
$0.91
-
$2.91
Sold -64k shares
Q3 2024
Avg closing price
$1.19
Price range
$0.95
-
$1.64
Sold 42.0% shares (-46.3k shares)
Q2 2024
Avg closing price
$1.45
Price range
$1.12
-
$1.87
Increased shares by 121.0% (+60.4k shares)
Q1 2024
Avg closing price
$1.63
Price range
$1.24
-
$2.18
Increased shares by 6.4% (+3k shares)
Q4 2023
Avg closing price
$1.24
Price range
$0.65
-
$2.30
Increased shares by 9.7% (+4.14k shares)
Q3 2023
Avg closing price
$0.95
Price range
$0.66
-
$1.20
Increased shares by 10.0% (+3.9k shares)
Q2 2023
Avg closing price
$1.11
Price range
$0.97
-
$1.34
Increased shares by 4.9% (+1.8k shares)
Q1 2023
Avg closing price
$1.15
Price range
$0.92
-
$1.48
Increased shares by 6.9% (+2.4k shares)
Q4 2022
Avg closing price
$1.42
Price range
$0.70
-
$1.98
Increased shares by 60.9% (+13.1k shares)
Q3 2022
Avg closing price
$3.03
Price range
$1.59
-
$5.06
Increased shares by 199.1% (+14.3k shares)
Q2 2022